Can a wearable posture coach ease back pain and stiffness?

NCT ID NCT07776652

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 21, 2026 · Updated 1 time

Summary

This trial tests whether adding a wearable postural biofeedback device to a standard exercise program can improve disease activity, pain, and function in people with axial spondyloarthritis, a type of inflammatory arthritis affecting the spine. Participants will do supervised exercises twice a week for 8 weeks, and some will also wear the device for at least 3 hours a day on three days each week. Researchers will compare outcomes like pain, spinal mobility, and quality of life between the two groups to see if the device adds extra benefit.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A wearable postural biofeedback device used alongside a standard exercise program
What this could lead to
If effective, this approach could offer a non-drug way to reduce pain and improve mobility and quality of life for people with axial spondyloarthritis.
What could go wrong
The trial is small (38 participants) and early, so results may not apply broadly. The device's benefit over exercise alone is uncertain, and adherence to wearing it may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 38 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Be between 18 and 65 years of age. * Have a diagnosis of ankylosing spondylitis or axial spondyloarthritis according to the modified New York or ASAS classification criteria. * Have had stable medical treatment with no changes in medication during the previous 3 months. * Have axial/spinal pain intensity of at least 4 out of 10 on the Numeric Pain Rating Scale during the previous week. * Be able to walk independently. * Voluntarily agree to participate in the study and provide written informed consent. Exclusion Criteria: * History of spinal surgery within the previous 6 months. * Any change in medical treatment, including biological agents or analgesic treatment, within the previous 3 months. * Presence of fibromyalgia or another secondary chronic pain syndrome that may substantially affect pain perception. * Serious cardiopulmonary, neurological, or orthopedic conditions that prevent participation in exercise. * Pregnancy. * Dermatological or allergic skin reactions or other skin conditions that prevent the use of the wearable device. * Regular participation in a structured exercise or rehabilitation program supervised by a physiotherapist for axial spondyloarthritis within the previous 3 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Ankylosing spondylitis (AS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Istanbul University-Cerrahpasa, Faculty of Health Sciences

    Istanbul, Istanbul, 34500, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.